A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses
Considering mAb LZY3412 has neutralizing effects on various flaviviruses, this mAb is expected to be developed as therapeutic or preventive drug for these flaviviruses, and can also be used to guide the development of vaccines against these flaviviruses.
Authors
- Hongxia Ni (ORCID: https://orcid.org/0009-0009-3519-024X)
- Yusha Liu (ORCID: https://orcid.org/0000-0001-9253-9916)
- Jinsheng Wen (ORCID: https://orcid.org/0000-0001-5864-1466)
- Jiayi Zhang (ORCID: https://orcid.org/0000-0002-1575-0723)
- Chen Dong (ORCID: https://orcid.org/0000-0002-0084-9130)
- Jie Chen (ORCID: https://orcid.org/0009-0002-3643-4866)
- Jiayang Zhu (ORCID: https://orcid.org/0000-0001-8574-1761)
Institutions
- Ningbo University (CN)
- Wenzhou Medical University (CN)
- Ningbo Center for Disease Control and Prevention (CN)
- Wenzhou Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2024-12-23
- DOI
- https://doi.org/10.3389/fmicb.2024.1508923
- Citations
- 2
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 1.09
Funders
- National Natural Science Foundation of China
- Ningbo University
- Natural Science Foundation of Ningbo
- Natural Science Foundation of Zhejiang Province